Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by AlienMummieon Dec 30, 2017 11:32am
118 Views
Post# 27251075

News from 22-02-17 sugest big revenu for NF to be disclose.

News from 22-02-17 sugest big revenu for NF to be disclose.
News Release (22-02-17):  
New Age Farm to Double Greenhouse Capacity at its Washington State Cannabis Facilities
Increased capacity can lead to tenant-grower revenues of up to $32 million per year

February 22, 2017- Vancouver, BC
New Age Farm Inc. (CSE:NF) (OTC:NWGFF) (FSE:ONF) (www.newagefarminc.com) (“New Age Farm” or the “Company”), has acquired a further 24,000 square foot greenhouse structure to augment the previously announced addition of a 21,000 square foot greenhouse (see news release dated November 29, 2016). By adding these two structures, totaling 45,000 square feet, to the existing 5,600 square foot state of the art facility completed in 2016Q4, New Age Farm’s Tier 2 and Tier 3 tenant-growers will be able to grow at full, 100% allowable I-502 capacity, year-round. The entire 45,000 square feet of greenhouse structure combines Cravo, Nexus and Hired Hand Green components for state of the art capabilities and 14 foot high trusses provide an ideal environment for growing large plants.
 
 
Revenue Potential
By operating at full capacity, our current tenant-growers will have potential for gross annual revenue from their crops of up to $32 million. New Age Farm’s potential revenues come from invoicing its tenant-growers. An increase in crop revenue means a direct increase in invoiced revenue for New Age Farm. Year-round growing of crops maximizes the revenue potential for New Age Farm and its tenant-growers.
The Company’s CEO, Carman Parente expanded: “When at full capacity and at maximum yield, our current Tenant Growers can generate approximately $32 million per year in gross revenues including flower sales, extracted oils, lotions, food additives, etc. Our Master Growers are on site to assist our tenant-growers achieve the best possible crop yields as well as using their distribution channels to assist in their product sales. We are looking forward to seeing our tenant-growers operating year-round at full capacity in 2017.”

Bullboard Posts